« Best of the Best for Q4-07 - ATW - Atwood Oceanics, Inc. Breakout? »

RGEN - Repligen Corporation Makes the UltraValue Stock List

1 December 2007
Author: site admin Posted under Investing, Stock Picks, UltraValue

Looking at the chart of RGEN - Repligen Corporation, it’s clear that many like their latest earnings report. RGEN, a Biopharmaceutical company, reported $1.29 a share versus a year ago loss of $0.03. This quarter benefitted from a $40.1 million legal settlement and revenue from its Protein A product, used to produce certain antibodies (hmm, not sure what that means).

Note, this is a Biopharmaceutical company and the large earnings number that got it to the UltraValue list was from a one time gain. None the less, it’s chart does look promising. If I were to pursue this one (and I’m not), I’d keep a short leash on it.

RGEN - Repligen Corporation - 11/9/2007 - $4.35


Leave a reply

You must be logged in to post a comment.